MobiHealth News December 16, 2020
It plans to unite stakeholders across the health spectrum to further policies, research practices and technology innovation for decentralized clinical trials.
The Decentralized Trials and Research Alliance (DTRA) recently launched to accelerate the broad adoption of patient-focused decentralized clinical trials and research.
It plans to unite stakeholders across the health spectrum to further policies, research practices and technology innovation for decentralized clinical trials.
The alliance is currently made up of more than 50 life sciences and healthcare organizations, including AstraZeneca, the U.S. Food and Drug Administration, Pfizer and others.
DTRA member organizations will help identify gaps in the space and provide expertise to advance best practices through education and communication. The alliance is currently accepting organizations on its website.
WHY...
Today's Sponsors
Today's Sponsor